Prognostic significance of heat shock protein 90AA1 (HSP90α) in invasive breast cancer

被引:6
作者
Alsaeed, Sami A. [1 ,2 ]
Toss, Michael [1 ]
Alsaleem, Mansour [1 ,3 ]
Aleskandarany, Mohammed [1 ]
Joseph, Chitra [4 ,5 ]
Kurozumi, Sasagu [1 ,6 ]
Ball, Graham [7 ]
Mongan, Nigel [8 ,9 ]
Green, Andrew [1 ]
Rakha, Emad [1 ,10 ]
机构
[1] Univ Nottingham, Nottingham Breast Canc Res Ctr, Sch Med, Biodiscovery Inst,Div Canc & Stem Cells, Nottingham, England
[2] Northern Border Univ, Fac Appl Med Sci, Ar Ar, Saudi Arabia
[3] Qassim Univ, Onizah Community Coll, Dept Appl Med Sci, Qasim, Saudi Arabia
[4] Univ Nottingham, Sch Med, Nottingham, England
[5] Nottingham Univ Hosp NHS Trust, Nottingham City Hosp, Nottingham, England
[6] Int Univ Hlth & Welf, Dept Breast Surg, Narita, Japan
[7] Nottingham Trent Univ, John van Geest Canc Res Ctr, Sch Sci & Technol, Nottingham, England
[8] Univ Nottingham, Fac Med & Hlth Sci, Biodiscovery Inst, Nottingham, England
[9] Weill Cornell Med, Dept Pharmacol, New York, NY USA
[10] Menoufia Univ, Fac Med, Shebin Al Kawm, Egypt
关键词
breast neoplasms; pathology; molecular; breast diseases; lymph nodes; EXPRESSION; HSP90; INHIBITION; INDEX; AKT; APOPTOSIS; SURVIVAL; BINDING; BASAL;
D O I
10.1136/jclinpath-2020-207106
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims The mechanisms that drive breast cancer (BC) progression and poor outcome are not fully understood. The human heat shock protein 90 alpha family class A member 1 (HSP90 alpha) encoded by the HSP90 Alpha A1 gene has a vital role in cellular responses to stress and is implicated in the development and progression of many cancers. The current study aims to explore the clinical and prognostic importance of HSP90 alpha in BC. Methods The Molecular Taxonomy of Breast Cancer International Consortium (n=1980); The Cancer Genome Atlas (n=1097) and the Breast Cancer Gene-Expression Miner (Bc-GenExMiner) BC datasets (n=5056) were used to evaluate HSP90 Alpha A1 mRNA expression. HSP90 alpha protein expression was further assessed using immunohistochemistry in a large (n=911) well-characterised BC series. The association between mRNA and protein expressions with other clinicopathological parameters and outcome was analysed. Results High expression of HSP90 Alpha A1 both at the mRNA and protein levels was significantly associated with characteristics of BC poor prognosis, including high grade, lymphovascular invasion, poor Nottingham Prognostic Index and positive expression of p53 and PIK3CA. Outcome analysis revealed that high HSP90 alpha protein expression is an independent predictor of shorter BC-specific survival. Conclusion HSP90 alpha can be used as a potential prognostic marker in BC. Further mechanistic studies are warranted to determine the underlying molecular mechanisms mediated by HSP90 alpha in BC.
引用
收藏
页码:263 / 269
页数:7
相关论文
共 54 条
[41]   Nottingham Prognostic Index Plus (NPI plus ): a modern clinical decision making tool in breast cancer [J].
Rakha, E. A. ;
Soria, D. ;
Green, A. R. ;
Lemetre, C. ;
Powe, D. G. ;
Nolan, C. C. ;
Garibaldi, J. M. ;
Ball, G. ;
Ellis, I. O. .
BRITISH JOURNAL OF CANCER, 2014, 110 (07) :1688-1697
[42]   Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes [J].
Rakha, Emad A. ;
Elsheikh, Somaia E. ;
Aleskandarany, Muhammed A. ;
Habashi, Hany O. ;
Green, Andrew R. ;
Powe, Desmond G. ;
El-Sayed, Maysa E. ;
Benhasouna, Ahmed ;
Brunet, Jean-Sebastien ;
Akslen, Lars A. ;
Evans, Andy J. ;
Blamey, Roger ;
Reis-Filho, Jorge S. ;
Foulkes, William D. ;
Ellis, Ian O. .
CLINICAL CANCER RESEARCH, 2009, 15 (07) :2302-2310
[43]   The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer [J].
Rolland, Phil ;
Spendlove, Ian ;
Madjid, Zahra ;
Rakha, Emad A. ;
Patel, Poulam ;
Eljis, Ian O. ;
Durrant, Lindy .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (06) :1311-1317
[44]   HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer [J].
Rumman, Marufa ;
Jung, Kyung Hee ;
Fang, Zhenghuan ;
Yan, Hong Hua ;
Son, Mi Kwon ;
Kim, Soo Jung ;
Kim, Juyoung ;
Park, Jung Hee ;
Lim, Joo Han ;
Hong, Sungwoo ;
Hong, Soon-Sun .
ONCOTARGET, 2016, 7 (47) :78029-78047
[45]   The Contrived Mutant p53 Oncogene - Beyond Loss of Functions [J].
Sabapathy, Kanaga .
FRONTIERS IN ONCOLOGY, 2015, 5
[46]   Modulation of Akt kinase activity by binding to Hsp90 [J].
Sato, S ;
Fujita, N ;
Tsuruo, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) :10832-10837
[47]   TP53: an oncogene in disguise [J].
Soussi, T. ;
Wiman, K. G. .
CELL DEATH AND DIFFERENTIATION, 2015, 22 (08) :1239-1249
[48]  
Tomczak K., 2015, Contemp Oncol (Pozn), V19, pA68, DOI DOI 10.5114/WO.2014.47136
[49]   Effects of treatment with an Hsp90 inhibitor in tumors based on 15 phase II clinical trials [J].
Wang, He ;
Lu, Mingjie ;
Yao, Mengqian ;
Zhu, Wei .
MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (03) :326-334
[50]   Heat shock proteins: A review of the molecular chaperones [J].
Whitley, D ;
Goldberg, SP ;
Jordan, WD .
JOURNAL OF VASCULAR SURGERY, 1999, 29 (04) :748-751